Timothy Hughes, MD
Obstetrics & Gynecology · Mobile, ALNPI 1740223742
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $141,728 of the $149,467 with a category attached, or 94.8%. Organon accounts for 77.1% of it on its own, with 2 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $658.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$115K
- Merck$34K
- Genentech USA, Inc.$47
What the payments were for
- Speaking & faculty fees$141,72895%
- Travel & lodging$6,5904%
- Food & beverage$1,1481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 174 | $115,272 |
| Merck | 50 | $34,147 |
| Genentech USA, Inc. | 3 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$146,505
How this compares
$149,467 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 29 | $434 |
| Azithromycin | 54 | $247 |
| Doxycycline Hyclate | 25 | $232 |
| Fluticasone Propionate | 15 | $191 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $59 |
| Amoxicillin | 13 | $39 |
| Meloxicam | 16 | $28 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mobile
- Allison CalhounMobile$132K
- Melinda FrameMobile$16K
- Phillip MadoniaMobile$14K
- Quin BixlerMobile$12K
- Amy McCoyMobile$10K
- Jessica JonesMobile$9K
- Margaret KruegerMobile$7K
- Theodore CatranisMobile$7K
- Lauren LambrechtMobile$6K
- Patton Morrison-BartonMobile$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.